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Abstract
Background: Autologous chondrocyte implantation is an established technique for the repair of
degenerated articular cartilage. Recently, the detection of side population (SP) cells, which have the ability
to strongly efflux Hoechst 33342 (Ho) fluorescence dye, has attracted attention as a method of stem cell
isolation. Although SP cells from synovial tissue were expected to be an excellent source for this tissue
engineering, their precise character in the synovial tissue has not been determined.
Methods: Synovial tissues from bovine metacarpophalangeal joints were used as a stem cell source. For
efficient collection of stem cells, we first prepared a preculture before sorting in medium containing FBS
at variable concentrations for 4 days. Using a cell sorter and the Ho-dye, a poorly stained population
enriched with stem cells was then isolated. To determine the characteristics of the stem cells, specific
marker genes such as CD34, Flk-1, c-Kit, Abcg-2 were identified by real-time PCR. Sorted SP cells were
cultured in a stem cell medium supplemented with bFGF, SCF and fibronectin, and evaluated for their
differentiation potentials into chondrocytes, osteocytes and myocytes.
Results: SP cells of synovium tissue were increased from 2% of the total cell population to approximately
10% of the total cells by preculture in the 1%FBS contained medium. Sorted SP cells expressed CD34, Flk-
1, c-Kit, Abcg-2 and Mdr-1 -all are important marker genes for stem cell characteristics. The SP cells could
be further expanded ex vivo while maintaining stem cell potentials such as marker gene expression, Ho-dye
efflux potential and multiple differentiation potentials into chondrocyte, osteocyte and myocyte.
Conclusion: In the present study, we demonstrated that the cells with outstanding stem cell properties
were efficiently collected as a SP fraction from bovine synovial membrane. Furthermore, we have
described an efficient isolation method and the culture conditions for ex vivo expansion that maintains their
important characteristics. Our results suggest that the SP cells of synovium tissue might be important
candidates as sources for cell transplantation.
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Lesions on articular cartilage are difficult to heal sponta-
neously, and there is no effective strategy for inducing
their repair. Autologous chondrocyte implantation (ACI)
is now an established technique for the repair of sympto-
matic isolated lesions of articular cartilage in young adults
[1,2]. However, surgical invasion of normal articular car-
tilage and limited ex vivo expansion of the chondrocytes
lead to difficulties in repairing large defects.
Stem cells from synovium membrane have been viewed as
fascinating potential sources for regenerative medicine
since they possess high chondrogenic properties [3,4] and
are possible to be prepared from the joint without damag-
ing the healthy articular cartilage. However, the specific
cell markers of these have not yet been determined, and a
way for efficient purification also has not been developed.
Recent developments in stem cell biology demonstrated
the presence of side population (SP) cells. They are iden-
tified by their unique fluorescence-activated cell sorting
(FACS) profile, regardless of tissue origin. When separated
by a flow cytometer with a UV laser, SP cells are distinct
from cells that take up the Hoechst 33342 (Ho) dye [5].
The SP phenotype is determined by the BCRP1/ABCG2
gene that is expressed in pluripotent ES cells and multipo-
tent somatic stem cells [6]. Isolation of SP stem cells by
the Ho-dye and FACS technique has been reported in
muscular tissue [7,8], liver [9,10], lung [11], skin [12],
uterus [13], testis [14] and cornea [15,16] at present.
It was reported that SP stem cells of bone marrow origin
displayed strong hematopoietic reconstituting activity as
measured by competitive repopulation assays [5], and
marrow SP cells also give rise to endothelial cells and skel-
etal and cardiac muscles [7,8,17]. Moreover, SP cells from
the skeletal muscle might be reconstituted as both the
skeletal muscle and the hematopoietic system of recipi-
ents. From these, it is expected that the SP stem cells of
somatic tissues possess superior properties, and it is easy
to surmise that SP cells in synovium tissues also possess
valuable properties compared to other types of somatic
cells, and are expected to be a better source of regenerative
medicine.
SP stem cells of synovium tissue have been found by
Yamane et al., to possess high chondrogenic properties
[18]; however, the precise characteristics such as stem cell
marker gene expression profiles or multiple differentia-
tion properties were not determined. Furthermore, the
culture system for the SP stem cells has not been devel-
oped.
In the present study, we determined that the SP cells
expressed important stem/progenitor cell markers CD34,
Flk-1, c-Kit and Abcg-2, and they possessed multiple dif-
ferentiation potentials to differentiate into chondrocyte,
osteocyte and myocyte. Furthermore, we also succeeded
in expansion in vitro without losing these properties. Our
method suggests a way to amplify necessary stem cells
from a little volume of tissue, it might be an effective way
to prepare materials for regenerative medicine.
Methods
Preparation of synovial cells
Fibrous synovial membrane (wet weight 1.5–2.5 g) was
obtained aseptically from the metacarpophalangeal joint
of freshly slaughtered calves about 10 months of age,
which was kindly gifted from the local slaughterhouse.
The specimens were rinsed twice with PBS supplemented
with penicillin, streptomycin and amphotericin B, and
minced well. They were then digested with 0.1% colla-
genase (Sigma-Aldrich, St. Louis, MO, USA) in Dulbecco's
modified Eagle's medium (DMEM-1; Nissui Pharmaceuti-
cal, Tokyo, Japan) containing 10% fetal bovine serum
(FBS; Hyclone Laboratories Inc., Logan, UT, USA. Lot no.
KPK22095) and Penicillin – Streptomycin – Amphoter-
icin B mixture (Antibiotic-Antimycotic; Invitrogen Corpo-
ration, Carlsbad, CA, USA.) for 8 hours at 37°C.
Following digestion, the cells were filtered through a 100-
μm mesh. The filtrate was centrifuged, washed twice with
PBS and stored on ice until further use.
Hoechst 33342 exclusion assay using fluorescence-
activated cell sorting
Released cells were resuspended at a concentration of 106
cells/ml in FACS buffer composed of DMEM (DMEM-2;
Nissui Pharmaceutical) plus 2% FBS, 10 mM HEPES and
antibiotics. For preliminary study, we performed
Hoechst33342 (Ho; Sigma-Aldrich. Lot no. 017K4122)
staining at various concentrations (1, 1.2, 1.4, 1.6, 1.8, 2,
3, 4 and 5 μg/ml) followed by FACS analysis, and con-
firmed optimal concentrations as 1.8 to 2.0 μg/ml in our
system. For analyzing the rates of SP fractions, cell suspen-
sions were incubated in FACS buffer containing Ho-dye at
1.8 μg/ml for 90 minutes at 37°C. For sorting, cells were
stained with 2.0 μg/ml under the same conditions to per-
form subsequent analysis closely. As a negative control for
the Ho staining, 50 μM verapamil (Ver; Sigma-Aldrich.
Lot no. 096K4617), which blocks the ABC membrane
transporter from extruding the Hoechst dye, was added to
an aliquot of cell solution. After staining, cells were
washed twice with ice-cold FACS buffer, centrifuged and
resuspended. Cell sorting was performed using a dual-
laser fluorescence-activated cell sorter (FACS VantageSE,
Becton Dickinson, San Jose, CA, USA). Ho was excited by
an argon multiline UV laser (333.4- to 363.8-nm;
COHERENT, Santa Clara, CA, USA.), and fluorescence
emission was detected through 450-nm band-pass
(Hoechst blue) and 675-nm long-pass (Hoechst red) fil-Page 2 of 13
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both blue and red were collected as SP cells. Stained con-
trol cells were classified as non-side population (NSP)
cells.
Preculture for efficient collection of SP cells
Digested and filtered cells were cultured on gelatin-coated
dishes at 1.5 × 106 cells/100-mm dish in DMEM or Stem-
Pro-34SFM (Invitrogen) supplemented with antibiotics,
0.1 mM pyruvate and 1, 5, 10, 15% FBS. After 4 day's cul-
ture, the cells were released from culture dishes with
0.25% trypsin-0.02% EDTA for 3 min, centrifuged and
washed with 10% FBS-containing DMEM. The cells were
then used for FACS sorting.
Ex vivo expansion of sorted SP cells
Precultured and sorted SP cells were plated onto fibronec-
tin (Fn; BD Falcon, Oxnard, CA, USA) coated 24-well
dishes at 10,000 cells per well in Stem Pro-34SFM supple-
mented with 1%FBS, 10 ng/ml human recombinant basic
FGF (bFGF; Upstate, Charlottesville, VA, USA), 25 ng/ml
human recombinant stem cell factor (SCF; Peprotech Inc.,
Rocky Hill, NJ, USA) and insulin-transferrin-serenium
(ITS-G; Invitrogen). When 80%–90% confluent, cells
were trypsinized and subcultured on Fn coated 35 mm
dishes at 5 × 104 cells per dish. After passaging to 35 mm
dish, the culture medium was changed every other day.
Passaging was performed every 3 days and continued 12
times.
In vitro differentiations into chondrocytes, osteocytes and 
myocytes
Precultured and sorted cells were harvested onto fibronec-
tin-coated dishes, and cultured in 1% FBS containing
StemPro-34SFM supplemented with 10 ng/ml human
recombinant basic FGF (bFGF; Upstate, Charlottesville,
VA, USA), 25 ng/ml human recombinant stem cell factor
(SCF; Peprotech Inc., Rocky Hill, NJ, USA) and insulin-
transferrin-serenium (ITS-G; Invitrogen). To confirm the
differentiation potency, we used 7-times passaged cells for
the differentiation experiment.
The in vitro chondrogenesis assay was performed by pellet
culture. 2.0 × 105 viable SP and NSP cells were centrifuged,
and the cells were cultured in DMEM (Nissui Pharmaceu-
tical) supplemented with 5%FCS, ITS, 10 ng/mL trans-
forming growth factor β1 (TGF-β1) (R&D Systems,
Abingdon, UK), 10 nM dexamethasone (Sigma-Aldrich),
10 mg/mL ascorbic acid (Sigma-Aldrich), and antibiotics
(Invitrogen). After 3 weeks, pellets were fixed with 10%
formalin, embedded in tissue-tek compound, sectioned at
7-μm and stained with toluidine-blue and alcian-blue
according to standard protocols using cryosections pre-
pared from a bovine articular cartilage as controls [see
Additional file 1].
For osteocyte induction, cells were plated at 3 × 103/cm2
in 12-well tissue culture plate and cultured in 10%FBS-
DMEM contained 100 nM dexamethasone, 10 mM ascor-
bic acid, and 2-glycerophasphate. Differentiated samples
were tested for alkaline phosphatase (ALP) activity by
alkaline phosphatase kit (SIGMA-Aldrich) and calcium
deposition by staining with 1% Alizarin red-S solution.
For myocytes differentiation, cells were plated to fibronec-
tin-coated 35-mm dishes and cultured in DMEM high-
glucose, 1%FBS, antibiotics and 0.1 mM Pyruvate. After a
week, the cultures were fixed, permeabilized by 0.5% Tri-
ton-X (SIGMA-Aldrich) diluted in PBS (0.5% PBT),
blocked with 5% skim milk (SIGMA-Aldrich) and incu-
bated with anti-DESMIN rabbit IgG polyclonal antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:50
dilution) and kept overnight at 4°C. For immunofluores-
cence microscopy, the samples were incubated for 1 h at
room temperature with FITC-conjugated bovine anti-rab-
bit IgG antibody (Santa Cruz Biotechnology, 1:1000 dilu-
tion). These samples were counterstained with propidium
iodide (PI) before observation.
RNA extraction and real-time PCR analysis
Sorted cells and cultured cells were treated with TRIzol
reagent (Invitrogen) and mixed thoroughly with pipet-
ting. To dissociate the pellets of chondrocyte obtained by
differentiation assay, the pellet was disrupted using a 21-
G needle and syringe in TRIzol reagent. The Trizol-lysates
were then mixed with chloroform and centrifuged at
15,000 × g for 15 minutes. Following centrifugation, total
RNA were obtained by isopropanol precipitation accord-
ing to the manufacturer's instructions. Single strand cDNA
was prepared from total RNA using Random primer under
standard conditions with the High Capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA,
USA). Quantitative real-time PCR with total cDNA was
performed using Perfect real-time SYBR green (Takara Bio,
Inc., Shiga, Japan). PCR amplifications were performed
with the 7700 real-time PCR System (Applied Biosystems)
at 95°C for 10 sec followed by 40 cycles of 95°C for 5 s,
60°C for 30 s. To quantify the relative expression of each
gene, the Ct (threshold cycle) values were normalized for
endogenous reference (delta Ct = Ct target- Ct β actin) and
compared with a calibrator, using the "delta-delta Ct
method" (delta-delta Ct = delta Ctsample - delta Ctcalibrator)
[19]. As a calibrator, we used the average Ct value of syn-
ovium tissues obtained from three different animals.
Using the delta-delta Ct value, relative expression was cal-
culated (2-deltadeltaCt). As the delta Ct method is only appli-
cable when the amplification efficiencies of the target and
the reference are essentially equal, we determined the effi-
ciencies for 5 dilutions, and the delta Ct values (Cttarget-
Ctβ actin) were plotted against the dilution (log). The slope
of the fitted line was then determined. A slope of less thanPage 3 of 13
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shown). The target genes in the present experiment were
CD34, Flk-1, c-Kit, Abcg-2 and Mdr-1. All experiments
included negative controls consisting of no cDNA for each
primer pair. All samples were tested in duplicate, and the
average values were used for quantification. Primers were
designed to span exons to distinguish cDNA from
genomic DNA products (Table 1).
RT-PCR analysis for evaluation of differentiation
The cDNA from each sample was diluted and used for an
RT-PCR-based assay for type I collagen (COL1A1), type II
collagen (COL2A1), CD-RAP, Aggrecan, Myo-D, Myf-5
and Osteocalcin. PCR amplifications were performed at
95°C for 2 min followed by 35 cycles of 94°C, 20 s; 58°C,
20 s; and 72°C, 20 s using Platinum Taq PCRx DNA
polymerase (Invitrogen) with appropriate primers accord-
ing to the manufacturer's instructions. All primers for PCR
were designed on two different putative exons so as to
span one intron or designed to span a putative exon-exon
junction. Amplicons were analyzed by agarose-gel electro-
phoresis and ethidium bromide-staining.
Statistical analysis of the data
Significant difference was detected by one-way ANOVA
analysis followed by Tukey's multiple comparison tests.
Comparisons between cultured SP cells and cultured NSP
cells were performed by student t-test, and gene expres-
sion alteration after passages of SP cells were evaluated by
Dunnet's test using the values of the SP cells at primary
culture as controls. A P-value of less than 0.05 was consid-
ered significant.
Results
Characterization of SP cells in synovial tissue
Bovine synovial cells were stained with the vital DNA dye,
Hoechst 33342, and excited by a UV laser. Usually, the SP
cells exhibit a low blue (440- to 460-nm) and low red
(>675-nm) fluorescent staining pattern. This pattern is
created by an efflux of the Hoechst 33342 dye from the SP
cells. In case of the bovine synovial cells, three distinct
regions were observed after excluding dead cells and
debris. The cells included in population 1 (P1) and popu-
lation 2 (P2) were smaller than that of population 3 (P3),
and no adherent cells were observed when they were
seeded on culture dishes. On the other hand, population
3 consisted of fibroblast-like cells and included a distinct
side population (SP) (Figure 1). The dye exclusion prop-
erty of SP cells is partly due to the functional ABC trans-
porters and verapamil effectively blocking the ABC
membrane transporter from extruding the Hoechst dye
[20-24]. With the addition of verapamil, the presence of
the SP fraction in region 3 was clearly eliminated [see
Additional file 2], indicating that the cells in this region
were candidates for stem cells. The SP cells expressed stem
cell maker genes such as CD34, Flk-1, c-Kit, Abcg-2 and
Mdr-1.
Preculture for expansion of SP cell
From the gene expression profiles, SP cells in P3 might be
stem cells in synovial tissues. However we found that the
proportion of SP cells was less than 2%, and it was clear
that cell number enhancement is necessary to obtain the
cells efficiently. We examined several culture conditions
to amplify SP cells. This procedure was also reported to be
effective for collecting SP cells from a small amount of tis-
sues, such as corneal stroma [15]. When synovial tissue-
derived cells were cultured in ordinary medium (DMEM
Table 1: Primers using the characteristics of SP cells and differentiated cells
NCBI Gene ID Forward Reverse Amplicon
β-actin 280979 AGGTCATCACCATCGGCAAT; ex 3* GAATGCCGCAGGATTCCAT; ex 4 87 bp
CD34 281051 TGCTATTTCCTGATGAACCGC; ex 7 TCCACGTAATAAGGGTCTTCGC; ex 8 74 bp
Flk-1 407170 TTCCAAGTGGCTAAGGGCAT; ex 22 TTTAACCACGTTCTTTTCCGACA; ex 23 102 bp
c-Kit 280832 CAAGGAAGGTTTCCGAATGC; ex 19 CCCAGCAGGTCTTCATGATGT; ex 20 74 bp
Abcb-1 (Mdr-1) 281585 GCAAAGCAGGCGAGATCC; ex 17 TCAATGCTCCCGTGGTGTT; ex 18 111 bp
Abcg-2 (Bcrp-1) 536203 CCTTGGTTGTCATGGCTTCA; ex 14 AGTCCTGGGCAGAAGTTTTGTC; ex 15 98 bp
Pcgf-4 (Bmi-1) 510666 GGCTGGAACCGCCTAAAAC; ex 1 TCTGCTTGATAAAAGATCGGCTC; ex 1–2 91 bp
COL1A1 282187 ATGGCGAAGCTGGAAAG; ex 9–10 CCACTGAAACCTCTGTGT; ex 11–12 121 bp
COL2A1 282189 TGGTATCGCCGGACCCAAG** CTCGTCCACCGTCCTTCCC** 82 bp
Aggrecan 280985 CACCTGTAAAAAGGGCACAGTG; ex 15 GCATTGATCTCGTATCGGTCC; ex 16 95 bp
CD-RAP 280857 TGACCGGAAGATGTGTGCC; ex 2 CACGTAGTCCTGAAGGGCCA; ex 3 73 bp
MyoD-1st 281938 CAAACGCAAGACGACTAACG; ex 1 TGTAGTAAGTGCGGTCGTAG; ex 2 392 bp
MyoD-2nd 281938 AACGCCATCCGCTATATCG; ex 1 TGTAGTCCATCATGCCGTCG; ex 2 187 bp
Myf-5 281335 ACATTGAGAGTCTGCAGGAG; ex 1 TTGCTCTGAGTTGGTGATC; ex 3 269 bp
Osteocalcin 281646 AGATGCAAAGCCTGGTGATG; ex 2 ATGTGGTCAGCTAGCTCGTC; ex 4 192 bp
*Number of exons (ex) to which the primer binds.
**Detailed information has not been reported.Page 4 of 13
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Flow cytometric characterization of SP cellsigure 1
Flow cytometric characterization of SP cells. (A) Bovine synovial cells were stained with Hoechst 33342, and excited by 
a UV laser. Populations including SP cells were determined by live/dead evaluation using PI, single/doublet cells evaluation using 
FSC-A/SSC-A and microscopic evaluation (B). SP patterns were visible after Hoechst 33342 staining in population 3 (P3). P1 
and P2 consisted of small, non-adherent cells.
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Expansion of SP cells by precultureFigure 2
Expansion of SP cells by preculture. (A-a) Synovial tissue-derived SP cells were cultured in the DMEM (solid rectangles) or 
StemPro-34SFM (SFM; shaded rectangles) with different concentration of FBS. Data represent the mean ± S.D. of 6 experi-
ments. Asterisks indicate statistically significant difference (P < 0.01) between control (tissue) evaluated by Dunnet's test. Dif-
ferent characters indicate statistically significant difference (P < 0.05) determined by ANOVA and Tukey's multiple comparison 
tests. (A-b) SP region expanded by preculture in 1%FBS supplemented SFM (upper panel). The regions were determined by 
verapamil treatment (lower panel). (B) Phase-contrast images of precultured cells in SFM supplemented with 1% FBS. In the 
condition, small cell colonies could be observed (arrow). Phase-contrast images of the sorted cells (right). Right-upper panels 
show SP cells (scale bar = 200 μm) and high-magnification image of these (scale bar = 100 μm). Right-lower panels show NSP 
cells and high-magnification images of these.
BMC Musculoskeletal Disorders 2008, 9:86 http://www.biomedcentral.com/1471-2474/9/86containing 10% FBS), only fibroblast-like cells with larger
cytoplasm grew rapidly, while the rate of SP cells did not
increase (Figure 2). In the culture using DMEM, altering
the FBS concentration did not affect the rate of SP cells.
Then, we used stem cell specific medium StemPro-34SFM.
Unexpectedly, synovial tissue-derived cells neither
adhered to the culture plate nor multiplied under serum-
free conditions [see Additional file 3]. The result suggested
that additions of growth factors and/or cell adhesion mol-
ecules contained in serum are essential to the survival of
synovial tissue derived cells. Accordingly, we tested serum
addition to the medium at various concentrations. The
rate of cell adhesion and growth was significantly
enhanced when serum was added at 1 to 5% concentra-
tions to the medium.
In contrast, less than 1% serum addition could not sup-
port cell adhesion and proliferation, and over 10% serum
addition significantly diminished the expansion of SP
cells. In 1% FBS containing StemPro-34SFM, small spin-
dle-like cells were expanded, and formations of small col-
onies were observed. Therefore, we determined the ideal
culture condition for the synovial SP cells to be 1% FBS
containing StemPro-34SFM.
Characteristics of SP cells
After preculture in 1% FBS containing StemPro-34SFM,
we examined the characterization of cultured SP cells for
the stem cell markers. The SP cells showed significantly
higher expression, than NSP cells, of somatic stem cell
marker genes CD34, Flk-1, and Abcg-2 (Figure 3).
Culturing and analysis of SP cells
To stably supply transplantable cells, ex vivo amplification
of the cells was required. Because we showed that SP cells
in the synovial tissues could be amplified using precul-
tured medium, i.e. SFM and 1% serum, sorted SP cells
were cultured under the same condition; however, the SP
cells after sorting did not adhere and proliferate. It is pos-
sible that, in primary culture, co-existence of variable
types of cells including blood cells secret some cytokines
or cell adhesion molecules in an autocrine or paracrine
fashion, and support the adhesion and proliferation of SP
cells. Next, we examined the effect of bFGF, SCF and
fibronectin on the adhesion and growth of the SP cells.
Sorted SP cells exhibited small spindle-like features and
formed colonies when cultured in the condition with
these supplementations, on the other hand, NSP cells did
not form colonies, and the proliferation speed was low. In
the culture condition, the SP cells exhibited logarithmic
proliferation even after 10 passages and Ho-efflux proper-
ties were also maintained. Furthermore, the SP cells
expressed marker genes CD34, Flk-1, c-Kit and Abcg-2
(Figure 4).
Determination of multiple differentiation potentials
To confirm the multilineage differentiation potential, SP
cells, which were expanded ex vivo and passaged more
than 7 times, were induced to differentiate into chondro-
cyte, osteocyte and myocyte. In chondrogenic culture, the
cell pellets became spherical, and the pellets from SP cells
tended to have greater amounts of cartilage matrix than
did pellets from NSP cells as shown by staining with tolu-
idine blue and alcian blue. RT-PCR analysis demonstrated
further characterization of chondrogenesis, and chondro-
cyte specific genes COL2A1, CD-RAP and Aggrecan were
determined.
SP cells also had differentiation potentials to become
osteocyte and myocyte. About the osteogenic potentials,
no remarkable difference was observed between the ori-
gins, i.e. SP cells and NSP cells. On the other hand, myo-
genic property was only observed in SP cells. Desmin
expressing myocytes were detected in the derivatives of SP
cells, and these cells expressed other myogenic marker
genes Myf-5 and Myo-D (Figure 5).
Discussion
In the present study, we determined stem cell specific
marker gene expression of SP cells in bovine synovial
membrane, and constructed a culture system for efficient
collection and ex vivo expansion of the stem cells.
Recently, Yamane et al. reported that the SP fraction was
only 0.6 % in the synovium tissues at the medial and lat-
eral femoral condyles of 3-month-old calves [18]. On the
other hand, we observed SP fractions in about 2 % of the
total cells. Furthermore, the flow cytometric profile of the
two reports was totally different. This discrepancy might
be due to differences of tissue origins, it is possible that
the numbers of SP cells were different in the area of syn-
ovium tissues. Another factor might be based on the dif-
ference in the cell sorting condition. For instance, they
used 10 μg/ml of Hoechst 33342 dye and we used it at 1.8
– 2.0 μg/ml. The experiment for determination of SP cells
was dependent on the staining protocol which is subject
to variations in timing, temperature, cell concentration,
and Ho-dye concentration. We first determined the gene
expression profile of bovine synovium SP cells using some
stem cell markers such as CD34, c-Kit, Flk-1, Abcg-2 and
Mdr-1. CD34 is a transmembrane sialoglycoprotein
expressed by early hematopoietic stem cells [25]. Flk-1 is
a receptor for vascular endothelial growth factor, and a
marker for progenitor cells of hematopietic and endothe-
lial lineage [26]. C-Kit, also known as CD117, is a receptor
for stem cell factor and is expressed in various stem cells
and hematopoietic progenitor cells [27,28]. Abcg-2 is the
molecular determinant for the SP phenotype and has
been postulated as a universal stem cell marker [29].
These gene expressions were observed in some somatic
stem cells, and it is thought these are important for stemPage 7 of 13
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2008, 9:86 http://www.biomedcentral.com/1471-2474/9/86
Page 8 of 13
(page number not for citation purposes)
Analysis of the stem cell marker gene expressions based on quantitative RT-PCRFigure 3
Analysis of the stem cell marker gene expressions based on quantitative RT-PCR. (A) Expression scores were 
obtained by the delta-delta Ct calculation method. All values are mean ± S.D. of 5 samples of SP (S) and NSP (N), and 6 sam-
ples of precultured SP (cS) and precultured NSP (cN). Significant differences were observed using ANOVA and Tukey's multi-
ple comparison tests. Asterisks on bars indicate significant differences (P < 0.05). (B) Gel electrophoresis pattern recognition 
of real-time PCR products. Total RNA without reverse transcribed samples (RT-) were used as negative control.
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Characteristics of SP cells on ex vivo expansionFigure 4
Characteristics of SP cells on ex vivo expansion. (A-a) Phase-contrast images of cultured SP cells. Scale bar = 100 μm. 
(A-b) Colony-forming assay with the SP cells. SP cells were seeded at a density of 500 cells per a fibronectin coated 35-mm 
dish. (A-c) Cell proliferation speed was markedly promoted by addition of growth factors and fibronectin addition. Values are 
the mean and SEM of 3 independent cell lines. (B) Ho-staining and FACS analysis of ex vivo expanded SP and NSP cells. Open 
triangles indicate the populations possessing Ho-efflux properties. The NSP cells did not represent the Ho-efflux property. All 
experiments were performed using 6 times passaged cells, and replicated 3 times using 3 independent cell lines. (C) Analysis of 
the stem cell marker gene expressions based on quantitative RT-PCR in ex vivo expanded SP cells. Y-axis represents the rela-
tive values for SP cells of primary culture (correspond to the mean values of cS in figure 3A). Significant differences between 
primary SP cells and 7 times passaged SP cells were observed by Dunnet's test. Significant differences between passaged SP cells 
and passaged NSP cells were observed by student t-test.
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Evaluation of differentiation properties of SP cellsFig re 5
Evaluation of differentiation properties of SP cells. (A) In vitro chondrogenesis. SP and NSP cells were cultured for 21 
days in TGF-β contained chondrocyte differentiation medium. (A-a) Pellets were stained with toluidine blue and alcian blue. (A-
b) Expression of chondrogenic genes was also examined. SP and NSP cells were cultured for 21 days, and chondrocyte specific 
gene expressions were determined by RT-PCR analysis. Representative data were shown with 3 experiments. (B) In vitro oste-
ogenesis. SP and NSP cells were cultured for 21 days in osteocyte differentiation medium. (B-a) ALP activity was determined in 
both derivatives. (B-b) Calcium deposition was examined by 1% Alizarin red staining, High-magnification image of stained cells 
derived from SP cells were shown in right panel. Scale bar is 200 μm. (B-c) Expression of osteocyte specific gene Osteocalcin 
was determined by RT-PCR. (C) In vitro myogenesis. SP and NSP cells were cultured for 7 days in myocyte differentiation 
medium. Desmin expressions were determined by immunocytochemical staining (C-a; scale bar = 100 μm), and high-magnifica-
tion image of SP derived myocyte (C-b; scale bar = 50 μm). (C-c) Myocyte specific gene expressions were determined by RT-
PCR.
BMC Musculoskeletal Disorders 2008, 9:86 http://www.biomedcentral.com/1471-2474/9/86cell characteristics mainly to maintain their stem-ness.
The synovium SP cells also expressed these markers and
there was also additional evidence for stem cells.
Although the stem cells collected as SP cells possessed val-
uable characteristics for stem cell based therapy, the
important factor in tissue engineering is to harvest the
greatest number of cells with the highest potential while
minimizing the amount of mesenchymal tissue needed,
for less-invasive treatments. In this context, clearly the
most important contribution of our study is the finding
that the SP cells could be expanded ex vivo under specific
conditions. We found that a combination of 1% FBS and
StemPro-34SFM is ideal for enhancing SP cell prolifera-
tion. Under this condition, the rates of SP fractions were
up to over 8% of total cells. Interestingly, increased sup-
plementation of serum to over 10% inhibited the prolifer-
ation of the SP cells [see Additional file 4]. It is possible
that the high serum concentration induced SP cells to dif-
ferentiate into somatic cells and promoted expansion of
differentiated cells, which caused the relative rate of SP
fractions to decrease.
On the other hand, under the conditions of less than 1%,
adherent cells were decreased and getting enough cells for
cell sorting was difficult. When SP cells were cultured in
StemPro-34SFM with 1% FBS, the expressions of stem cell
markers were maintained. When ordinal culture medium
DMEM was used as basement medium, effects for expan-
sion and decreasing the rates of SP fractions dependent on
serum concentrations were not observed. StemPro34-SFM
is a medium specifically developed for CD34 expressing
hematopoietic stem cell culture and the effects for other
types of stem cell such as spermatogonial stem cells were
reported [30-32]. Although the mechanism or molecules
by which the expansion of SP cells were stimulated in the
medium is not known, the factors necessary for the main-
tenance of these stem cells are the defined components of
StemPro34-SFM, and may be shared with hematopoietic
stem cells.
To achieve further enhancement of the cell number, we
then examined the conditions for ex vivo expansion of
sorted SP cells. For maintaining the SP cell proliferation
while keeping their specific characters as stem cells, we
found that the supplementation with three factors (bFGF,
SCF and Fn) was effective. The FGF families are important
factors for proliferation of variable stem cells such as mes-
enchymal stem cell (MSC) [33,34], neural stem cell [35],
and embryonic stem cell [36,37]. SCF plays an important
role via a c-Kit receptor in the recruitment of adult hemat-
opoietic stem cells [27], or formation of germ stem cells in
vivo [28]. Also in vitro, SCF is an essential factor for the
maintenance of hematopoietic stem cell [38-40]. Fn is a
kind of extra-cellular matrix glycoprotein, which func-
tions in promoting cell adhesion. In hematopoietic tis-
sues, stem cells adhere to the Fn and endothelial vascular
cell adhesion molecule (V-CAM) by integrin and cell sur-
face glycosaminoglycans [41]. And the molecule func-
tions as the crucial factor for maintenance of ex vivo
culture [41,42]. The above culture condition enables the
logarithmic expansion while maintaining some impor-
tant original characteristics. After continued passaging
and culturing, the expression of CD34, Flk-1 and Abcg-2
mRNA was still maintained at a high-rate compared with
NSP cells. Importantly, this Abcg-2 mRNA expression
reflected as the phenotype that the cultured SP cells also
represented the Ho-efflux properties and Ver-sensitivity.
However, the FACS profiles were little different from the
original profiles of SP fractions. It was supposed that the
valance of the two kinds of Ho-efflux proteins Abcg-2 and
Mdr-1 were altered from original cells. This profile was
observed only in SP cell derivatives, and it was lost with
differentiation (data not shown).
Recently, it was reported that cells expressing CD34 and
CD117 (c-Kit) exist at <2%, and cells expressing Flk-1
exist at <4%, in synovial tissues [4]. Although the expres-
sion of these molecules was an important phenotype of
stem cells, the expression of Flk-1 was diminished by ex
vivo culture when cultured in normal medium [43]. The
SP cells cultured in our system maintained other markers
CD34, Flk-1 and c-Kit expressions. From these, our system
might be suitable for maintaining undifferentiated stem
cells in synovium tissues.
Furthermore, we also demonstrated multiple differentia-
tion potentials for synovial SP cells into chondrocyte,
osteocyte and myocyte. In our study, NSP cells used as
control also possessed differentiation properties to differ-
entiate into chondrocyte and osteocyte. It was hypothe-
sized that NSP fractions might include some kind of
progenitor cells that could differentiate into chondrocyte
or osteocyte. On the other hand, myogenic properties
were only observed in SP cells. As stimulating chemicals
for myogenic differentiation from somatic stem cells such
as MSC in vitro, 5' azacytidine that is an analog of cytidine,
were used [43,44]. The chemical functions by incorpora-
tion into DNA, and results in hypomethylation of the
DNA. On the other hand, transplantation to muscular tis-
sues also induces myocyte differentiation from MSCs
derived from synovium tissues [45]. However, in our
study, the SP cells could differentiate to myocyte without
the chemical or transplantation, about 1% of derivatives
expressed Desmin, a muscle-specific intermediate fila-
ment protein. These results mean that the myogenesis
from SP cells might occur as the "forward" differentiation,
and suggested that the SP cells maintained high differen-
tiation potentials.Page 11 of 13
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BMC Musculoskeletal Disorders 2008, 9:86 http://www.biomedcentral.com/1471-2474/9/86Conclusion
We first demonstrated the capacity of SP cells in the syno-
vial tissue to proliferate ex vivo and differentiate into
chondrocytes, osteocytes and myocytes. Although further
studies are required to demonstrate that SP cells are trans-
plantable stem cells after ex vivo expansion, the present
findings might lead to the development of an effective
method for preparing materials for cell-based therapy.
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